HIIFS
PACB icon

Harel Insurance Investments & Financial Services’s Pacific Biosciences PACB Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-20,000
Closed -$1.67M – 837
2020
Q4 		$1.67M Buy
+20,000
New +$340K 0.04% 214

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Harel Insurance Investments & Financial Services's PACB Position: Q1 2021 in Review

Harel Insurance Investments & Financial Services sold out of Pacific Biosciences (PACB) in Q1 2021, closing a stake of 20,000 shares — an estimated $1.67M sold.

Harel Insurance Investments & Financial Services first reported a position in PACB in Q4 2020 and held it in 1 quarter. The position peaked at $1.67M in Q4 2020. 263 funds tracked by Wall St. Rank hold PACB as of Q1 2021.

  • Harel Insurance Investments & Financial Services reported no remaining Pacific Biosciences position as of Q1 2021 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 20,000 Pacific Biosciences shares in Q1 2021, an estimated $1.67M.
  • Harel Insurance Investments & Financial Services first reported a position in Pacific Biosciences in Q4 2020 and held it in 1 quarter.
  • Harel Insurance Investments & Financial Services's Pacific Biosciences position peaked at $1.67M in Q4 2020.
  • 263 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2021.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2021, filed 27 Apr 2021.